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S96Objective: Currently, in Middle Europe, closed and open mitral valve commissurotomy (MVC) is rarely done
and has been replaced by catheter-based balloon procedures. Especially under these circumstances, data on the
long-term outcomes after surgical interventions are important.
Methods: From 1955 to 1989, 268 patients (75 male and 193 female patients) with mostly rheumatic or infec-
tious mitral stenoses underwent closed (n¼ 151) or open (n¼ 117) surgical procedures. Themean age at surgery
was 41.2  11.1 years; 19 patients (7.1%) died within the first 30 days after surgery.
Results: The 50-year follow-up was complete for 215 patients (80.2%). The survival rate at 10, 20, and 30 years
after surgery was 80.2%, 58.6%, and 41.8%, respectively. The differences after closed and open MVC were
nonsignificant. At the latest follow-up, 32 patients were alive and had a mean New York Heart Association func-
tional classification of 2.7. The 10-, 20-, and 30-year freedom from reoperation rate was 93.2%, 82.9%, and
76.0% for the closed intervention group and 88.5%, 80.3%, and 78.7% for the open intervention groups. Again,
the differences were nonsignificant. The main cause for reoperation was recurrent fibrosis of the mitral valve.
Most patients (n ¼ 51) received mechanical valves, 5 a bioprothesis, and 8 repeat MVC. Four patients required
a third intervention.
Conclusions: In Middle Europe, closed and open MVCs are now rarely performed, but the ultra-long-term
results are excellent and serve as a standard for the now-established balloon valvuloplasty. MVCs remain an
option for pregnant women. In third world clinical conditions, closed MVC remains a less expensive
alternative. (J Thorac Cardiovasc Surg 2012;143:S96-8)In Middle Europe, acute rheumatic disease, a leading cause
of mitral stenosis, is now very rare, unlike in other parts of
the world, such as Eastern Europe, Asia, South America,
and Africa. Currently, European patients with mitral valve
stenoses (eg, after inflammatory endocarditis) are treated
with balloon valvuloplasty, typically performed by inter-
ventional cardiologists.
In our unit at the University ofMunich, Rudolf Zenker be-
gan performingmitral valve commissurotomy (MVC) in the
1950s. The ultra-long-term results after surgical closed and
open MVC are the purpose of our retrospective study.MATERIALS AND METHODS
FromAugust 1955 to September 1989, 268 patients with valvular mitral
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The Journal of Thoracic and Cardiovascular Surg(56.3%) were treated with closed and 117 (43.7%) with open procedures.
In the mid-1970s, the closed procedure was replaced by open techniques.
The main cause of disease was rheumatic fever, followed by endocarditis
and rare congenital lesions. The mean age at surgery was 41.2 11.1 years
(range, 3 months to 67 years). Preoperatively, most of the patients were
very sick and belonged to a New York Heart Association functional classi-
fication of III or IV.
The differences between the 2 groups—treated with closed and open
techniques—were not statistically significant, except for their age at sur-
gery: 38.4  10.6 years versus 43.9  11.3 years.
All patient chartswere reviewed. If the late outcomes remainedunknown,
questionnaires were sent to the patients. When necessary, the patients, their
physicians, or relatives were interviewed. If the outcome remained un-
known, the local authorities were asked for help. The institutional review
board of the University of Munich approved the present study.
The outcomes were identified in 215 (80.2%) of the 268 patients. The
remaining living patients underwent clinical examinations, including echo-
cardiograms and electrocardiograms.
Operative Techniques
In the early days, significant mitral valve stenosis was identified using
physical signs, electrocardiographic changes, and type of valvular murmur
on auscultation. Mitral valve calcifications and the left atrium size were as-
sessed on the lateral chest radiograph and after a barium swallow. Closed
MVCwas performed using the classic method by way of a left anterolateral
thoracotomy. The Tubbs dilator was inserted through the left ventricular
apex. The surgeon’s finger within the left atrium guided the instrument
through the diseased valve.
In the mid-1970s, open MVC replaced the closed procedure using the
heart–lung machine and techniques as described by Carpentier.1 Open val-
votomies were performed by way of a right anterolateral incision or median
sternotomy.ery c April 2012
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MCV ¼ mitral valve commissurotomyFIGURE 2. Intraoperative view (left anterolateral incision) of repeat
closed mitral valve commissurotomy. Small felt cylinder attached to atrial
appendage and Tubbs dilator positioned within the left ventricular apex.Statistical Analysis
Kaplan-Meier long-term survival and freedom from reoperation curves
were performed. Statistical significance was tested using log-rank statis-
tics.2 Probability values less than .05 were considered significant.
RESULTS
Early Mortality
Altogether 19 patients (7.1%) died within the first 30
days postoperatively (12 patients after closed and 7 after
open MVC). Most (n ¼ 13) died of insufficient relief
of the stenosed valve. Two patients died of postoperative
myocardial infarction and four of noncardiac causes. In
the patients who underwent a closed procedure, mortality
was due to excess commissurotomy in 9 and resulted in
severe valvular incompentence and, ultimately, death.
Kaplan-Meier Survival Curve
The survival rate at 10, 20, and 30 years after surgery was
80.2%, 58.6%, and 41.8%, respectively. Dividing the sur-
vival curve into closed and open MVC groups, 82.1%,
64.9%, and 45.7% of the closed group and 77.8%,
50.3%, and 37.1% of the open group were alive after 10,
20, and 30 years (Figure 1). The differences between the
2 cohorts were nonsignificant (P ¼ .121, log-rank test).
Altogether 32 of the operated patients were alive at the
time of the present study; 13 underwent closed and 19
open interventions. Almost all patients (n¼ 29) had chronicURE 1. Kaplan-Meier survival curve after surgery, divided into
sed and open mitral valve commissurotomy.
The Journal of Thoracic and Caratrial fibrillation. The mean New York Heart Association
classification of the surviving patients was 2.7.Reoperations
The freedom from reoperation rate also revealed non-
significant differences between the closed and open
MVCs. After 10, 20, and 30 years, 93.2%, 82.9%, and
76.0% patients who underwent closed and 88.5%,
80.3%, and 78.7% who underwent open MVCs required
no additional interventions. In total, 51 patients had
mechanical valves, 5 had biologic valve replacements,
and 8 had repeat MVC (Figure 2). In 4 patients, a third
intervention was necessary. Five survivors required no
additional surgical treatment.DISCUSSION
Mitral valve stenosis is an important pathologic feature
after acute rheumatic fever—a condition that is none exis-
tent in current native Middle European population. The dis-
ease might, however, be present in immigrants (eg, from
Eastern European, Asian, or African countries), where
rheumatic fever is still endemic. There are of course other
inflammatory causes leading to mitral stenosis.
For decades, surgical closed or open MVCs were the
treatment of choice for these patients. Open procedures be-
came the preferred method since the 1970s.3 In 1984, Inoue
and colleagues4 introduced percutaneous balloon valvot-
omy that very soon virtually replaced any surgical interven-
tions in Middle European countries. Comparing the results
of surgical and interventional outcomes, it is difficult to
prove any superiority of the various techniques. In a recent
review of 7 prospective randomized and 5 case-controlled
trials from 1966 to 2010, Hu and Zhao5 found no significant
difference in respect to mortality ranging from 1 to 7 years.
The pooling analysis, however, revealed a significantly
greater occurrence of new-onset mitral regurgitation anddiovascular Surgery c Volume 143, Number 4S S97
Rheumatic Reichart et allate repeat interventions because of restenosis after balloon
valvuloplasty relative to patients undergoing surgical
MCVs.
In developing countries, the cost could also be another
consideration when comparing balloon devices with steril-
ization of mitral valve dilators.
The recent survey by Hu and Zhao5 once more confirmed
that long-term follow-up after surgical MVC are necessary
to compare these with the upcoming data after interven-
tional balloon valvuloplasty. Our 10-, 20-, and 30-year sur-
vival rate of 82.1%, 64.9%, and 45.7% for closed MVCs
and 77.8%, 50.3%, and 37.1% for open MVCs and the
freedom from reoperation rate of 93.2%, 82.9%, and
76.0% and 88.5%, 80.3%, and 78.7%, respectively, could
therefore serve as a standard. No differences were found
when comparing the results of the open and closed proce-
dures. These findings are interesting in the content of devel-
oping countries such as in Africa, in which open surgical
commissurotomy is still a less-expensive life-saving option.S98 The Journal of Thoracic and Cardiovascular SurgIn Middle Europe, closed surgical procedures might
still be indicated during pregnancy, because in such situ-
ations, x-rays should be totally avoided.6 Open MVC is
indicated in the presence of a huge thrombus within the
left atrium.References
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